Against expectations, critically ill people in cardiogenic shock fared similarly receiving one widely used inotrope or another in the small DOREMI trial. Patients had the same clinical outcomes on ...
Start i.v. loop diuretics in the emergency department or clinic setting for significant fluid overload (class I, level B). The initial i.v. dose should equal or exceed the long-term oral daily dose.
BANNOCKBURN, Ill., May 16, 2018 – Survival may improve when advanced heart failure patients receiving home infusion of inotropic therapy are also receiving guideline-directed care, suggest results of ...
Please provide your email address to receive an email when new articles are posted on . Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and ...
Some heart failure clinics are offering outpatients infusions of inotropes, most often with milrinone, despite overwhelming evidence that the drugs are neither safe nor effective, according to a ...
Few front-line medications exist for treating hospitalized patients with acute decompensated heart failure, a stage of heart failure marked by heightened severity and often-lengthy hospital stays with ...
Patients with cardiogenic shock were assigned to receive milrinone or dobutamine for inotropic support. There was no significant difference between the two groups in the composite primary outcome of ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results